News
As of 1 October 2026, 93 patients have been enrolled in the trial. 25 sites are now activated for recruitment in Germany, the Netherlands, Spain and Australia. For Switzerland, the initiation is scheduled for Mid of October.
Trial teams of the sites who already enrolled patients
Hamburg
Berlin Vivantes
Lübeck
Lüneburg
Mannheim
Heidelberg
Erlangen
Essen
Charité Berlin
Neumünster
Bielefeld
Tübingen
Gießen
Marburg
Kiel
First trial site activated on 6 November 2025!
On 6 November 2025 the first study site in Germany - University Medical Center Hamburg-Eppendord (UKE) - has been initiated! This marks an important milestone and the official start of many more site initiations to come [...]
EAST-STROKE Investigator Meeting – Hamburg, 16 October 2025
We were delighted to meet the EAST-STROKE investigators, study nurses and further trial team members from Germany, the Netherlands, Switzerland, and Spain. It was a great kick-off for the trial, with inspiring discussions and strong team [...]
Regulatory approval received for Germany, Spain, and the Netherlands!
We are very pleased to share that we’ve received regulatory approval via CTIS for Germany, Spain, and the Netherlands! 🎉 This marks a major milestone in the EAST-STROKE trial – and now we can truly get [...]
Meet EAST-STROKE at the DGK Herztage
Dr. Märit Jensen will be available Friday afternoon, September 26, at booth 41 (AFNET) to answer your questions about the EAST-STROKE trial. Come by for a personal exchange and learn more about the trial's background, goals, [...]
Project booth at ESOC 2025 in Helsinki
During the European Stroke Organisation Conference 2025, held in Helsinki from May 21 to 23, the EAST-STROKE team actively showcased the project at a dedicated booth in the exhibition hall. The event provided a valuable [...]
Presentation at the AFNET/EHRA Consensus Conference
The project coordinator Prof. Götz Thomalla presented EAST-STROKE during the 10th AFNET (Artrial Fibrillation NETwork) / EHRA (European Heart Rhythm Association) Consensus Conference 2025 in Paris. The participants of these conferences are selected experts in [...]
